Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Personalized Devices Predict Cancer Drug Response
Two teams have developed tumor-implantable drug delivery devices to study real-time responses to multiple therapies in cancer patients.
So do those with mesothelioma, a rare, incurable type of lung cancer usually caused by exposure to asbestos. Merck & Co.'s hot new immunotherapy ...
PRINCETON, NJ, USA I April 21, 2015 I Advaxis, Inc.(ADXS), a cancer immunotherapy company, today announced the data of one clinical and two ...
BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces the publication of a ...
A recent cancer treatment method tries to stimulate the paralysed ... allows taking into consideration new methods of immunotherapy against cancer, ...
The findings were presented at the American Association for Cancer ... Thisimmunotherapeutic vaccine will now be evaluated in a larger phase II ...
Melanoma is the most dangerous form of skin cancer caused by damage to skin cells (usually by ultraviolet radiation from sunshine or tanning beds), ...
Day 4 of the annual meeting of the American Association for Cancer Research (AACR) seemed to be all about adoptive cell therapy. In this approach ...
The immune system is the body's main defense against any malignancy, including cancer. However, most cancers have developed ways to evade the ...
“One hallmark of cancer is immune evasion, in which the immune system does not mount an effective antitumor response,” wrote study authors led by ...
Health experts are pinning their hopes on a very powerful combination of drugs that can unleash the "sleeping" immune system and melt the cancer ...
Study Finds That Microinjection Platform Enables Assessment of Multiple Cancer Drugs Directly in ...
In addition to solely focusing on cancer cells, translation of CIVO to the ... the power of the immune system to treat cancer with minimal side effects.
They both involved drugs called "immune checkpoint inhibitors," which prod the immune system to attack and destroy cancer cells, Suzanne Topalian ...
“Cancer can create an immunosuppressive environment that enables it to avoid detection and evade destruction by the immune system,” said Jeremy ...
... immune-system cells could truly target and destroy the cancer that nearly ... Today, the 23-year-old returning college student is cancer-free, with no ...
BUFFALO, NY - A possible major breakthrough by Roswell Park Cancer ... a polio vaccine would stimulate the immune system or a tetanus vaccine.
Bursting Cancer’s Bubble
Scientists make oxygen-filled microbubbles designed to increase tumor sensitivity to radiation
Two agents, ipilimumab plus nivolumab, bested single agent for initial treatment of advanced disease. Read more
Pancreatic cancer in mice has been reversed with the introduction of a ... able to reverse the disease by turning cells back to their pre-cancer state.
Dual-energy CT (DECT) imaging has several potential applications in the detection, staging, and follow-up ofpancreatic cancer, according to a ...
One of the more serious side effects associated with incretin mimetics is pancreatic cancer. Concerns over pancreatic effects associated with incretin ...
A prospective study of retrospectively analyzed blood samples of patients with nonresectable pancreatic cancer found that plasma KRAS mutational ...
"Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States and Europe and continues to represent a high unmet ...
Eating close to bedtime 'could raise the risk of breast cancer'
Leaving longer between the last meal or snack of the day and breakfast lowers the chance of developing breast cancer
Women who fasted for longer overnight had lower blood sugar levels
Better control over blood sugar levels reduces the risk of breast cancer
Women who fasted for longer also ate fewer calories throughout the day
Vaccine 'teaches the immune system to recognise compounds in prostate cancer' to stop it coming back
Vaccine is made from pieces of a protein called TARP
TARP is found in about 95 per cent of prostate cancers
Studies show the protein can teach the immune system to attack cancer
Metformin use did not improve survival of patients with pancreatic ductal adenocarcinoma (PDAC) in a retrospective cohort study, according to data ...
(NBC) - A team of scientists may have discovered a new way of shrinking pancreatic cancer tumors. The discovery could have profound effects on how ...
Scientists have found a way to restore pancreatic cancer cells to their original state by introducing a protein, thereby offering a potential novel ...
(HealthDay News) -- Statin use is inversely associated with pancreatic cancer risk, with evidence of a sex-specific risk reduction, according to a study ...
Health Notes: Mayo study identifies which people with pancreatic lesions have highest risk of cancer
In rare cases, those lesions can develop into pancreatic cancer. ... profile of the patient who would be most at risk having lesions develop into cancer.
The first thing someone diagnosed with cancer often does is to "Google" it. For pancreatic cancer, they'll find the average life expectancy with ...
AstraZeneca has flagged olaparib as a potential $2-billion-a-year seller, based on ongoing Phase III studies in ovarian, breast, gastric and pancreatic ...
Bladder cancer has the highest recurrence rate of any solid tumor. Due to the need for life-long surveillance, the perpatient cost of managing bladder ...
AACR: Immunotherapy Combination Active in Advanced Melanoma
Treatment with nivolumab and ipilimumab in patients with advanced melanoma produced significantly higher rates of response and progression-free survival compared with ipilimumab alone.
Treatment with nivolumab and ipilimumab in patients with advanced melanoma produced significantly higher rates of response and progression-free survival compared with ipilimumab alone.
AACR: Pembrolizumab Improved Survival vs Ipilimumab in Advanced Melanoma
Treatment with pembrolizumab resulted in an estimated 6-month PFS rate that was almost double that of treatment with ipilimumab in advanced melanoma patients.
Treatment with pembrolizumab resulted in an estimated 6-month PFS rate that was almost double that of treatment with ipilimumab in advanced melanoma patients.
Are Prostate and Other Cancer Risks Overestimated?
Too many people are being screened, diagnosed, and treated for certain types of cancer, according to two cancer researchers.
Too many people are being screened, diagnosed, and treated for certain types of cancer, according to two cancer researchers.
Possible Association Between Simian Virus 40 and NHL Found
Researchers have found immunologic evidence that simian virus 40 (SV40) may be associated with non-Hodgkin lymphoma (NHL).
Researchers have found immunologic evidence that simian virus 40 (SV40) may be associated with non-Hodgkin lymphoma (NHL).
MRI Screening for Individuals at High Risk for Pancreatic Cancer
An MRI screening program for individuals at high risk for pancreatic cancer may be effective, according to the results of a short-term study.
An MRI screening program for individuals at high risk for pancreatic cancer may be effective, according to the results of a short-term study.
Older Early-Stage NSCLC Patients Benefit From Adjuvant Chemotherapy
Early-stage non-small-cell lung cancer patients over 70 years old derive a similar benefit as younger patients from adjuvant chemotherapy following surgical resection.
Early-stage non-small-cell lung cancer patients over 70 years old derive a similar benefit as younger patients from adjuvant chemotherapy following surgical resection.
Second-Line Ramucirumab/FOLFIRI Improves Survival in Metastatic CRC
Metastatic colorectal cancer patients had about a 1.5-month increase in overall survival when treated with second-line ramucirumab plus FOLFIRI vs FOLFIRI alone.
Metastatic colorectal cancer patients had about a 1.5-month increase in overall survival when treated with second-line ramucirumab plus FOLFIRI vs FOLFIRI alone.
Targeted Therapy Combo Shows Benefit in Breast and Ovarian Cancer
Combination treatment with the PARP inhibitor olaparib plus the PI3K inhibitor BKM120 showed a benefit in subsets of breast cancer and ovarian cancer patients.
Combination treatment with the PARP inhibitor olaparib plus the PI3K inhibitor BKM120 showed a benefit in subsets of breast cancer and ovarian cancer patients.
MPDL3280A Shows Activity in Triple-Negative Breast Cancer
In an ongoing study, the immunotherapy MPDL3280A continues to be well-tolerated and to show signs of activity in triple-negative breast cancer patients.
In an ongoing study, the immunotherapy MPDL3280A continues to be well-tolerated and to show signs of activity in triple-negative breast cancer patients.
Metastatic Prostate Cancer Patients Respond to PARP Inhibitor
Men with metastatic castration-resistant prostate cancer that had mutations in DNA repair genes were more likely to respond to the PARP inhibitor olaparib.
Men with metastatic castration-resistant prostate cancer that had mutations in DNA repair genes were more likely to respond to the PARP inhibitor olaparib.
HPV Vaccine Can Protect Against Previously Exposed Patients
The HPV 16/18 vaccine protects women from cervical, anal, and oral HPV infections that can lead to cancer, including some women previously exposed to HPV.
The HPV 16/18 vaccine protects women from cervical, anal, and oral HPV infections that can lead to cancer, including some women previously exposed to HPV.
PD-1 Inhibition Shows Promise in Advanced NSCLC
Inhibition of PD-1 with pembrolizumab was well tolerated and showed promising survival results in a large phase I trial of patients with advanced non-small-cell lung cancer (NSCLC).
Inhibition of PD-1 with pembrolizumab was well tolerated and showed promising survival results in a large phase I trial of patients with advanced non-small-cell lung cancer (NSCLC).
Nighttime Fasting Decreases Breast Cancer Risk
Women who spend less time eating each day and an increased amount of hours fasting overnight had a decreased risk of breast cancer.
Women who spend less time eating each day and an increased amount of hours fasting overnight had a decreased risk of breast cancer.
Science Daily Cancer News
The breast cancer screening guidelines proposed yesterday by the United States Preventive Services Task Force (USPSTF) would result in thousands of additional and unnecessary breast cancer deaths each year, according to radiologists at Loyola University Health System (LUHS).
For some time, cancer scientists have considered the toxin, alpha-amanatin derived from “death cap” mushrooms, as a possible cancer treatment. However, due to its penchant for causing liver toxicity, its potential as an effective therapy has been limited.
What makes triple negative breast cancer more lethal in African-American women than white women or women of European descent? A new study reveals specific genetic alterations that appears to impact their prognosis and ultimately survival rates.
Genomic profiling identifies genomic mutations in a gene associated with a rare subset of breast cancer, research shows -- mutations that cannot otherwise be identified with standard clinical analysis of cells and tissue. The findings could have therapeutic implications specific to this rare form of the disease, say the authors.
Tambahkan Komentar